Our Lady of the Lake Cancer Institute has launched a new hematologic malignancy cell therapy program, the first of its kind in Baton Rouge. The leaders of the program—Dr. Hana Safah, medical director of heme-malignancy and cell therapy, and Dr. Nakhle Saba, director of lymphoma and chimeric antigen receptor T-cell (CAR T-cell) therapy—moved from New
OLOL launches the first comprehensive cell therapy program in Baton Rouge
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
